AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ELI LILLY & Co Director's Dealing 2005

Aug 12, 2005

29745_dirs_2005-08-12_348ea38b-09d1-4d41-881a-ba0407d88444.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ISIS PHARMACEUTICALS INC (ISIS)
CIK: 0000874015
Period of Report: 2005-08-05

Reporting Person: LILLY ELI & CO (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2500000	Direct